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Abstract
The main purpose of this investigation is to distinguish the problematic tendencies of 
the health insurance market development in Ukraine and the competitive positions of 
the leading insurance companies on it. Accordingly, the issues of complex analysis of 
key indicators of the insurers’ competitiveness, and the issues of establishing the fac-
tors that determine the level of competition in the market become very urgent. The first 
30 insurers out of 50 were taken for the study, and they received about 90% of insur-
ance premiums for voluntary health insurance in Ukraine in 2017. The authors have 
made the assessment of the competitive environment of the health insurance market of 
Ukraine using the concentration index and the indicator of market competition, which 
resulted in defining the advantages and disadvantages of their application. Taking into 
account that the abovementioned indicators for assessing the competition in the insur-
ance market can provide only approximate results, which indicates the inadequacy of 
the conclusions about the effectiveness of business processes management on it, the 
authors offered a scientific methodological approach to assessing the market environ-
ment with the use of an integrated indicator of the voluntary health insurance market 
competitiveness. Herewith, such an integrated indicator is calculated in terms of three 
segments of the market: sickness insurance; voluntary medical insurance (continuous 
health insurance); medical expenses insurance, simultaneously taking into account the 
behavior of two indicators – concentration and market competition. As a result of the 
research, it was found that the highest level of market concentration is typical for sick-
ness insurance and it indicates a high monopoly in the market in terms of this segment. 
Thus, the integrated indicator allows to make a comprehensive investigation of market 
behavior of the market participants and to reveal the problematic tendencies of its 
competitive environment.
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INTRODUCTION
Competition in the health insurance market as an integral part of the 
market economy characterizes the process of interaction and struggle 
of the existing companies on it, potential partners and competitors, 
aimed at ensuring the most favorable position for the market partic-
ipant, which will provide it with the opportunity to protect against 
the competitive forces or influence on them for its own benefit, will 
create better conditions for the realization of insurance services, satis-
faction of the client’s needs and obtaining the economic remuneration. 
In order to study the main trends in the development of the health 
insurance market in Ukraine and the competitive positions of leading 
insurance companies, it is necessary to characterize the key indica-
tors of the insurers’ activity and analyze the factors determining its 
dynamics, define the level of competition in the market and outline 
the problems of the relationship between the insurers in a competitive 
market environment.
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Despite a significant number of insurers providing services for voluntary health insurance, it is not pos-
sible to consider the health insurance market to be competitive. This is evidenced by a number of fac-
tors. Firstly, in 2017, according to the volume of the insurance premiums, the first 30 insurers out of 50 
received about 90% of the insurance premiums from voluntary health insurance (continuous health in-
surance). Secondly, in the national practice, there is no comprehensive approach to assessing the level of 
competition in the insurance market, considering the lack of methodological and information support.
It should be noted that the insurance law does not contain any registered principles on compliance with the 
rules of competition in the insurance market; there is no methodology for evaluating a competitive market 
environment. In order to outline the competitive tendencies in the insurance sector, since 2003, the National 
Financial Services Commission has introduced a calculation of two competition indicators – the market 
concentration ratio and the Herfindahl-Hirschman Index. This is a positive aspect in the development of 
information provision of the insurance market that made it possible to assess the competitive behavior of its 
participants. In addition, the indicator of market concentration can be calculated independently on the ba-
sis of available information of the official website of the National Financial Services Commission. However, 
in order to assess the competitive environment of the health insurance market and increase the efficiency 
of business processes management on it, it is advisable to develop a scientific and methodological approach 
to assessing the market competition using an integrated indicator of the voluntary health insurance mar-
ket competitiveness, the parameters of which can describe the competitive tendencies of the insurers who 
dominate on the market, the strategy of their market position and allow to use measures on adoption of 
reasonable decisions due to the regulation of the health insurance market development.
1. LITERATURE REVIEW
The main goal of the medical insurance market 
development is improving the medical services 
system. In this issue, all efforts should be direct-
ed at increasing the responsibility and interest of 
all market entities in the reform process. The re-
sult should be a high level of medical care in our 
country.
In general, taking into account the high impor-
tance of the health care system, the development 
of the insurance market should be formed in the 
direction of social and economic efficiency. In this 
case, it is necessary to understand the crucial role 
of the interrelation of all economic and social pro-
cesses that occur in our country.
We agree with Tretyak (2017) who believes that 
the development of the health insurance market 
is related to the level of stability of the entire eco-
nomic system, since the health insurance market 
needs investments.
Zaychuk (2015) focuses on the motivational side 
of the issue, on the insufficient level of citizens 
income, on the lack of appropriate insurance 
traditions.
To assess the competitiveness of the market, it is 
very important to understand how much servic-
es the insurance medicine system should provide. 
Borisova (2017) has developed a diagnostic mod-
el for the socio-economic potential of the health 
insurance system. This made it possible to assess 
the direction of developing the health insurance 
system (Borisova, 2017).
The effectiveness of a company activity depends 
on many factors. Mamedova (2018) has formed a 
model that allows to determine the class of the in-
surance company in terms of competitiveness.
On the other hand, the level of income of insur-
ance companies depends on the income of their 
clients. Eckles, Saardchom, and Powell (2011) con-
ducted a scientific research of the influence of dif-
ferent types of heterogeneity of the economic sys-
tem on the performance indicators of firms oper-
ating in the market.
When reforming the health insurance market, it 
is necessary to take into account the experience of 
those countries that have effectively implemented 
the changes. Parente (2011) conducted a research 
of the need of effective information system crea-
tion for implementing the basics of health.
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We support the ideas of Kozmenko and Lysenko 
(2014) who believe that an effective health insur-
ance market is impossible without creating an 
international system for monitoring the qual-
ity of health care with the involvement of all 
stakeholders.
2. AIMS
The purpose of the study is to identify (develop) an 
integrated indicator of the competitiveness assess-
ment of the voluntary health insurance market that 
will provide comprehensive coverage research of 
market behavior and competitive environment on it.
3. METHODS
The methodological basis of the study is based on 
systematic and dialectical approaches to the gen-
eral theoretical comprehension of medical insur-
ance as an important segment of the population 
insurance protection system. In this research, 
such methods were used: 
• methods of comparative analysis and syn-
thesis – to study modern organizational and 
methodological approaches to assess the com-
petitive environment of the market; 
• observation method – to detect the condition 
and problems of the health insurance market; 
• method of induction and deduction – to as-
sess the level of the health insurance market 
competitiveness; 
• method of system analysis – to substantiate 
the integrated index of the voluntary health 
insurance market competitiveness. 
4. RESULTS
In this article, we will characterize these indica-
tors and determine their advantages and disad-
vantages. So, the market concentration ratio (mar-
ket monopolization, CR) is calculated in several 
ways. The most commonly used is the way where 
this figure is calculated as the combined share 
of the largest market participants for the receipt 
of insurance/earned premiums (Baranov, 2011; 
Hamankova, 2009; Yermoshenko, 2006; Pavliuk 
& Stepanova, 2014). 
According to another group of scientists, the con-
centration of the insurance market should be de-
termined by other criteria: the size of the rein-
surance premiums, insurance (reinsurance) pay-
ments, reflecting the development of the insurance 
(reinsurance) activities; the size of assets, capital, 
reserves, which characterize the financial capabil-
ities of market participants (Bilous, 2013; Kneisler, 
2012). We believe that the use of a whole range of 
criteria in calculating the market concentration 
indicator allows us to assess the competitive ten-
dencies comprehensively in the insurance market.
However, taking into account the advantages of 
the concentration coefficient, which consists in 
the simplicity of the calculations, the availability 
of the analytical base, this indicator of competi-
tion has the main disadvantage – it does not fully 
characterize the potential of market power, since it 
is “insensitive” to different variants of shares dis-
tribution between the competitors and does not 
reflect the distribution of shares within the groups 
of the largest firms (Zhuk, 2011).
The level of market concentration depends on the 
number of participants on it and their size. The 
fewer insurance companies operate in the insur-
ance market and the more they vary in size, the 
higher will be the level of market concentration 
and monopolization. In addition, the concentra-
tion indicator determines the behavior of the in-
surance market participants, because at its high-
er level, their dependence on the competitors 
increases.
The indicator of market competition (Herfindahl-
Hirschman Index, HHI) is calculated as the sum of 
the squares of the shares of all insurance companies 
operating on the insurance market. The advantage 
of the Herfindahl-Hirschman index over the con-
centration coefficient is that it takes into account all 
subjects of the insurance market; therefore, it as-
sesses the degree of monopolization and the level of 
market concentration comprehensively. The maxi-
mum value of this indicator is 10,000 (NNI = 100² 
= 10,000), which indicates the presence of one in-
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surance company, which owns the entire insurance 
market, that is, the monopolization of the market 
by one company. The smaller is the index value, the 
more insurers there are on the market and the more 
competitive it is considered to be.
In national and foreign practices, the most popular 
is the methodology according to which the value 
of the market competition indicator is determined 
by such a scale (Homellia, 1998; Baye, 2007):
1)  ННІ < 1,000 – the market is assessed as low 
concentrated and highly competitive;
2) 1,000 < ННІ < 1,800 – the market is consid-
ered to be moderately concentrated, and the 
competition is weak and undeveloped;
3)  ННІ > 1,800 – the high concentration of mar-
ket power is observed, the market is low com-
petitive (with an approximate value of 10,000, 
it is reasonable to assume that there is no com-
petition in the market).
The main disadvantage of the market competition 
indicator is the complexity of the calculations, the 
need for information on the market share of all in-
surers. Herewith, the Herfindahl-Hirschman Index 
does not make it possible to identify the oligopoly 
of a dominant set of small oligopolists with one or 
two major competitors, that is an oligopoly oppo-
site to the oligopoly of a dominant company market 
with a competitive environment (Kneisler, 2012).
It should be noted that the two abovementioned in-
dicators of competition are determined only for the 
entire insurance market or its two segments – the 
general insurance market and life insurance market. 
However, to assess the competitive environment of 
the voluntary health insurance market and to calcu-
late the real value of these indicators within a single 
market, it is appropriate to outline the boundaries 
of this market. Accordingly, the main criterion for 
choosing the limits of the voluntary health insur-
ance market will be its distribution into markets: 
health insurance (continuous health insurance), 
sickness insurance and medical expenses insurance.
The next step is to determine the parameters that 
are taken as the “size” of the subject of the voluntary 
health insurance market. For each segment of the 
voluntary health insurance market, the main indi-
cators of the size of its participant will be the volume 
of the insurance premiums and insurance refund 
payments.
In theory and practice, the scientific and methodo-
logical approaches to assessing the concentration of 
market power, in particular regarding the choice of 
the number of major insurers are ambiguous. Thus, 
according to official information of the National 
Financial Services Commission, the concentration 
indicators are calculated due to 3, 10, 20, 50, 100, 
and 200 insurers. In this case, the scale at which it 
would be possible to estimate the concentration level 
is not given. Furthermore, according to the method 
specified in the Law of Ukraine “On protection of 
economic competition”, the status of economic enti-
ties is considered to be monopoly (dominant), in re-
lation to which the combined share (Law of Ukraine 
of 11.01.2001 No. 2210-IІІ):
• of one entity in the market exceeds 35% (CR-1 
> 35);
• of three or two entities that occupy the largest 
shares in one market, exceeds 50% (50 < CR-3 
< 70);
• of five or four entities with the largest shares 
in one market exceeds 70% (CR-5 > 70).
According to this Law, the concentration of mar-
ket power is estimated only due to 1, 3 and 5 mar-
ket participants, and it cannot determine the re-
al trends of the competitive environment of the 
health insurance market.
Nechyporuk (2010), taking into account the main 
principles of the legislation described above, offers 
his own methodology for assessing the market 
concentration, where he considers that: 
• the market is highly concentrated if the value 
of the concentration factor is within 70% < CR 
< 100%; 
• the market is moderately concentrated 35% < 
CR < 70%; and 
• it is low concentrated CR < 35% (Kneisler, 
2012, p. 228). 
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The share of what number of the largest companies 
is used to identify these limits is not clear. Kneisler 
(2012) states that the national insurance market is 
the market of oligopoly of a dominant set of small 
oligopolists, and therefore considers it appropri-
ate to assess the market concentration applying 
the concept of the expected variations of Bowley, 
which is based on the determination of the con-
centration level of 4, 8, or 10 largest companies on 
the market in order to assess the influence degree 
of their behavior on market functioning.
Bilous (2013) offers a methodology for assessing 
the competition in the insurance market, based on 
the application of the concentration index (market 
share of three insurance companies, CR-3) and the 
Herfindahl-Hirschman Index. Herewith, depend-
ing on the values of these indicators, the markets 
are divided into:
• low concentrated market: CR-3 < 45%; ННІ < 
1,000;
• moderately concentrated market: 45% < CR-3 
< 70%; 1,000 < ННІ < 2,000;
• highly concentrated market: 70% < CR-3 < 
100%; 2000 < ННІ < 10,000.
In our opinion, the scale which is used by the au-
thor to classify the markets is not substantiated. 
Shirinian (2012) uses a similar methodology for 
assessing the insurance market competitiveness. 
She formulates an integrated indicator that simul-
taneously takes into account the behavior of two 
indicators of CR
4
 and ННІ:
4
.IC CR HHI= ⋅  (1)
The authors consider the abovementioned meth-
odology to be the most suitable for assessing the 
level of competition in the voluntary health insur-
ance market in the context of its main segments. 
Confirmation of this is, firstly, the calculation of 
the concentration index by the criterion of the 
combined market share of four companies, which 
is the basis for the classification of the markets 
of William Shepard, that is decisive for oligopo-
ly markets, including the national insurance mar-
ket; and secondly, the calculation of the integral 
index of market competitiveness that optimally 
combines the behavior of the concentration index 
and the Herfindahl-Hirschman Index; thirdly, the 
classification of markets by quantitative and qual-
itative criteria, which allows a complex and com-
prehensive assessment of the competition in the 
voluntary health insurance market.
At first, the concentration indicators of the vol-
untary health insurance market will be calculat-
ed due to selected characteristics (insurance pre-
miums and payments) for its largest participants 
(the first 30 insurance companies of health in-
surance market in terms of collected insurance 
premiums in 2017) and the level of market com-
petition according to the methodology of the 
National Financial Services Commission and the 
Antimonopoly Committee will be determined.
Concentration indicators of the health insurance 
market in terms of continuous health insurance, 
sickness insurance, medical expenses insurance, 
Table 1. Concentration indicators of the voluntary health insurance market with pointing out its 
components according to the selected criteria (as of January 1, 2018), %
Source: Calculated according to the data of Insurance TOP.
Criteria of the market participant/share 
in the market CR1 CR2 CR3 CR4 CR5 CR10 CR20 CR30
Medical insurance (continuous health insurance)
Insurance premiums 15.0 25.5 34.9 43.5 50.0 73.1 90.9 98.3
Insurance payments 16.2 29.4 40.1 49.6 56.0 80.1 93.4 99.9
Sickness insurance
Insurance premiums 38.6 63.8 76.0 81.3 85.9 95.3 98.4 99.9
Insurance payments 21.5 38.5 51.8 64.4 71.1 93.3 99.0 99.9
Medical expenses insurance
Insurance premiums 14.9 29.1 43.1 49.5 55.1 74.9 92.9 98.6
Insurance payments 19.0 33.6 45.6 55.7 61.4 84.1 96.3 98.9
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in particular by the first company (CR
1
), by the 
first two companies (CR
2
), by the first three com-
panies (CR
3
), etc., are presented in Table 1.
According to the data of Table 1, the degree of the 
health insurance market concentration, calculat-
ed in terms of its separate segments and selected 
criteria, is different. So, the highest level of mar-
ket concentration is in the sickness insurance. 
The concentration coefficient CR
2
 for the first two 
largest insurers is 63.8%, that is, the share of the 
first two companies in terms of insurance premi-
ums occupies more than half of the market of this 
type of insurance. At the same time, due to the 
insurance payments, the concentration level CR
2
 
for the first two insurers is lower 38.5%, but CR
3
 
for the three insurers reaches 51.8%. As a result, 
two to three insurers on the market provide virtu-
ally all the activities of the sickness insurance. In 
addition, the CR
10
 index for the first ten, CR
20
 for 
the top twenty largest companies that make the 
sickness insurance, is 95.3%, 98.4% (due to the in-
surance premiums) and 93.3%, 99.9% (due to the 
insurance payments). This indicates that the vol-
untary health insurance market for this segment 
is highly monopolized.
In accordance with the criteria of the 
Antimonopoly Committee, which define the mo-
nopoly position of the economic entities, the mar-
ket power is distributed among the participants of 
the voluntary health insurance market (sickness 
insurance) in the following way: 
• the share of the first largest insurance com-
pany in the market in terms of the insurance 
premiums is 38.6%, and in terms of the size of 
the insurance payments it is 21.5%; 
• the combined share of the first three largest 
companies is 76.0% and 51.8%; 
• the combined share of the first five insurers is 
85.9% and 71.1%. 
Thus, according to the volume of the insurance 
premiums, the share of the first largest company 
is outside the permissible limits (CR
1
 > 35) and ap-
proaches to the critical value, whereas in terms of 
the insurance payments it is lower than the initial 
value CR
1
 > 35, indicating a high probability of an 
individual dominance in the market. A similar dy-
namics is typical for the combined share of the first 
three companies, for which the level of concentra-
tion CR
3
 is bigger than the norm of 50% according 
to two criteria, and it characterizes the presence of 
“hard” oligopoly. In addition, if there is no compe-
tition among these major market participants, this 
indicates a collective monopoly. Under conditions 
of competition between them that is evidenced by 
a change in pricing policy, improving the quality 
of services and the effectiveness of marketing ac-
tivities, the market should be considered to be a 
competitive one.
Due to the segments of the voluntary health in-
surance (continuous health insurance) and medi-
cal expenses insurance, the level of concentration 
for CR
1
, CR
2
 is lower, and its value is within the 
permissible limits of the competitive environment 
in accordance with the antitrust laws. Thus, the 
share of the first large company is 15% (of continu-
ous health insurance) and 14.9% (medical expens-
es insurance) in terms of the insurance premiums, 
16.2% and 19.0% in terms of the insurance pay-
ments; the share of two large companies is (25.5% 
and 29.1%, and 29.4% and 33.6%). However, if you 
consider the concentration ratio (CR
3
,
 
CR
5
,
 
CR
10
), 
then it is worth noting that the voluntary health 
insurance market is highly concentrated, in par-
ticular, CR
5
 (for the insurers of continuous health 
insurance) is 50% and 56%, while CR
5
 (for the 
insurers of medical expenses insurance) is 55.1% 
and 61.4%. Thus, there is a tendency according 
to which five large companies provide more than 
a half of the insurance premiums and make the 
overwhelming majority of the insurance pay-
ments in the voluntary health insurance market.
Concerning the above mentioned information, it 
should be noted that the level of concentration of 
the voluntary health insurance market in all its 
segments is higher in terms of the insurance pay-
ments, and it testifies, on the one hand, the execu-
tion of the insurance obligations by the largest in-
surers under the contracts of health insurance and 
the distribution of market power between them, 
on the other hand, the growth of the loss-making 
nature of these types of health insurance.
The authors calculate the Herfindahl-Hirschman 
Index in the voluntary health insurance market, 
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which characterizes the distribution of market 
power among all its participants. Considering the 
three main segments of this market, which differ 
from each other by the main participants, we cal-
culate HHI for each of these segments, showed in 
Table 2.
Table 2. Herfindahl-Hirschman Index in the 
voluntary health insurance market, calculated on 
the basis of insurance premiums and payments 
(as of January 1, 2018)
Source: Calculated according to the data of Insurance TOP.
Feature of the market ННІ
Medical insurance (continuous health insurance)
Insurance premiums 693.05
Insurance payments 834.79
Sickness insurance
Insurance premiums 2,344.34
Insurance payments 1,362.97
Medical expenses insurance
Insurance premiums 816.84
Insurance payments 992.72
Data in Table 2 confirm the significant concentra-
tion of the voluntary health insurance market in 
case of sickness insurance. Thus, according to the 
HHI indices calculated due to the insurance premi-
ums indicators, this segment of the voluntary health 
insurance market is highly concentrated (HHI = 
2,344.34, that is > 1,800), and it indicates a lack of 
competition and the presence of a monopoly group 
of insurers. Herewith, due to the insurance pay-
ments of the insurance against sickness, HHI is low-
er than 1,800, which confirms the moderate concen-
tration of the market and weak competition.
The Herfindahl-Hirschman Index does not exceed 
1,000 in the abovementioned scale due to two oth-
er market segments (continuous health insurance 
and medical expenses insurance) that characterize 
the level of competition among the insurers. This 
means that the voluntary health insurance mar-
ket is unconcentrated and competitive according 
to these components, and it has a dominant set of 
small oligopolists.
The calculated values of HHI allow to state that an 
oligopolistic structure of the insurance activity in 
relation to continuous health insurance and med-
ical expenses insurance is typical for the national 
voluntary health insurance market.
The authors calculate the integrated indicator of the 
voluntary health insurance market competitive-
ness (IC) in terms of its three segments, simultane-
ously taking into account the behavior of two indi-
cators CR
4
 and HHI according to the formula and 
criteria given in the method of Shirinian (2012). 
Accordingly, the calculation of the CR
4
 indicator in 
terms of two segments of the voluntary health in-
surance market (continuous health insurance and 
medical expenses insurance) as of 2018 corresponds 
to the second level with a “satisfactory” rating (CR
4
 
= 43.5% and CR
4
 = 49.5%). This indicates a mod-
erate concentration of the insurance participants. 
The HHI values confirm the high competition in 
these segments of the insurance market. Herewith, 
a proportional distribution of participants is typi-
cal for the market of continuous health insurance 
that corresponds to the assessment of “good”, and 
the distribution of insurance services is uneven for 
the medical expenses insurance market (the assess-
ment is “satisfactory”) (Table 3).
Table 3. Competitiveness indicators of the 
voluntary health insurance market (continuous 
health insurance, medical expenses insurance 
and sickness insurance) in 2017
Indicators Criteria Characteristics of the 
market
Medical insurance (continuous health insurance)
CR
4
 = 43.5% 30% < CR4 < 60% The insurance market is moderately concentrated
ННІ = 693.05 100 ≤ ННІ ≤ 1,000 The competition level is high 
ІС = 173.63 30 < ІС ≤ 180
The insurance market is 
proportionally distributed 
among the participants. The 
competitiveness is high 
Sickness insurance
CR
4
 = 81.3% 80% ≤ CR4 ≤ 100%
The insurance market 
is characterized by high 
concentration 
ННІ = 2,344.34 200 ≤ ННІ ≤ 5,000 The competition is not developed 
ІС = 436.57 350 < ІС ≤ 650
The market concentration 
and monopolization are 
high. The competitiveness 
is weak and meets the 
conditions of monopoly 
competition 
Medical expenses insurance
CR
4
 = 49.5% 30% < CR
4
 < 60% The insurance market is moderately concentrated 
ННІ = 816.84 100 ≤ ННІ ≤ 1,000 The level of competition is high
ІС = 201.08 180 < ІС ≤ 350 The distribution of insurance services is uneven
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The insurance market against the disease is 
characterized by weak competition and the un-
even distribution of insurance services. This is 
evidenced by the integrated indicator of com-
petitiveness of this segment of the voluntary 
health insurance market (ІС ≈ 436, 57) and the 
value of HHI (2,344.34), which corresponds 
to the third level with an “unsatisfactory” rat-
ing. The value of CR
4
 indicator is unsatisfactory, 
which is 81.3%, and characterizes the insurance 
market as excessively concentrated. Thus, con-
cerning the analysis of the concentration of the 
reinsurance market participants due to certain 
criteria, we can make a conclusion that the na-
tional market of voluntary health insurance in 
terms of continuous health insurance and medi-
cal expenses insurance is characterized by the 
presence of a dominant group of small com-
panies, with a moderate concentration of their 
market power. Herewith, according to the HHI, 
the level of competition in these segments is 
high.
Herewith, according to the concentration index, 
the sickness insurance market is highly concentrat-
ed, in addition, a low monopolization is observed, 
where a monopoly group of large ten companies out 
of thirty-five took more than 80% of the insurance 
premiums.
In our opinion, the high level of concentration in the 
sickness insurance market shows, on the one hand, 
the positive trends, namely, the growth of confidence 
of the customers to the insurers who are able to pro-
vide a reliable insurance protection and guarantees to 
fulfill obligations under the insurance contracts and 
have a certain reputation and image on the market. 
On the other hand, the domination of large insurers 
on the voluntary health insurance market makes it 
possible to take on liability a significant amount of 
risks, obtaining high profits, that in future may neg-
atively affect their solvency and financial stability in 
particular, and the effectiveness of the functioning 
of the national voluntary health insurance market in 
general.
CONCLUSION
While assessing the competitive environment of the Ukrainian voluntary health insurance market by using 
the generally accepted methodology for assessing market concentration and competition in the insurance 
market, it has been established that: the highest concentration level of the market can be seen in sickness 
insurance, and it indicates a high monopoly in the market of voluntary health insurance in terms of this 
segment; due to the segments of voluntary medical insurance (continuous health insurance) and medical 
expenses insurance, the concentration level is lower, and its value is within the permissible limits of the 
competitive environment in accordance with the antitrust law. Taking into account the above study, we 
note that a separate use of the market concentration coefficients and the Herfindahl-Hirschman Index for 
assessing the competition in the insurance market can only give the approximate results, and it indicates 
the inadequacy of conclusions received by the analysis in the health insurance market. In order to evaluate 
the competitive environment of the health insurance market accurately and efficiently, we propose the ap-
plication of an integrated indicator of the competitiveness of the voluntary health insurance market in its 
three segments, simultaneously taking into account the behavior of two indicators CR
4
 and HHI. We be-
lieve that only this integrated indicator allows to investigate the market behavior of the market participants 
comprehensively and identify the problematic trends in its competitive environment.
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